Artemis Global Life Sciences Limited announced unaudited standalone earnings results for the second quarter and six months ended September 30, 2017. For the quarter, the company reported revenue from operation of INR 1.020 million against INR 1.020 million a year ago. Loss from operations before exceptional items and tax was INR 0.626 million against profit of INR 0.621 million a year ago. Loss from ordinary activities before tax was INR 1.764 million against profit of INR 0.621 million a year ago. Net loss for the period was INR 1.584 million against profit was INR 0.463 million a year ago. Basic and diluted loss per share before after extraordinary items were INR 0.02 against earnings per share were INR 0.01 a year ago. For the six months, the company reported revenue from operation of INR 2.040 million against INR 2.040 million a year ago. Profit from operations before exceptional items and tax was INR 0.604 million against profit of INR 1.214 million a year ago. Loss from ordinary activities before tax was INR 0.534 million against profit of INR 1.214 million a year ago. Net loss for the period was INR 0.687 million against profit was INR 0.898 million a year ago. Basic and diluted loss per share before after extraordinary items were INR 0.01 against earnings per share were INR 0.01 a year ago.